Literature DB >> 8119993

A purine-rich exon sequence enhances alternative splicing of bovine growth hormone pre-mRNA.

W P Dirksen1, R K Hampson, Q Sun, F M Rottman.   

Abstract

A previous study has demonstrated that deletion of a region within the last exon of bovine growth hormone (bGH) pre-mRNA results in almost complete retention of the upstream intron (Hampson, R. K., LaFollette, L., and Rottman, F. M. (1989) Mol. Cell. Biol. 9, 1604-1610). We now demonstrate that insertion of a simple purine-rich element (GGAAG), which is present within the deleted region, activates intron splicing upon expression in transfected cells. Moreover, several repeats of the GGAA(G) sequence restore splicing to near wild-type levels and direct the binding of a factor present in HeLa cell nuclear extracts. Mutation of the 5'-splice site toward U1 small nuclear RNA complementarity eliminates dependence on the downstream exon sequence for splicing. These results support a model for alternative intron retention in which purine-rich sequences function as part of an "exonic splicing enhancer" to complement a weak 5'-splice site and thereby facilitate intron removal. As a result, the majority of bGH mRNA is processed to remove intron D while still allowing a fraction of bGH mRNA containing the intact intron to reach the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8119993

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5' or 3' splice site activation.

Authors:  C F Bourgeois; M Popielarz; G Hildwein; J Stevenin
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Splicing enhancement in the yeast rp51b intron.

Authors:  D Libri; A Lescure; M Rosbash
Journal:  RNA       Date:  2000-03       Impact factor: 4.942

3.  SR proteins Asf/SF2 and 9G8 interact to activate enhancer-dependent intron D splicing of bovine growth hormone pre-mRNA in vitro.

Authors:  X Li; M E Shambaugh; F M Rottman; J A Bokar
Journal:  RNA       Date:  2000-12       Impact factor: 4.942

4.  The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers.

Authors:  Y Cavaloc; C F Bourgeois; L Kister; J Stévenin
Journal:  RNA       Date:  1999-03       Impact factor: 4.942

5.  SR proteins and hnRNP H regulate the splicing of the HIV-1 tev-specific exon 6D.

Authors:  Massimo Caputi; Alan M Zahler
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

6.  Roles of hnRNP A1, SR proteins, and p68 helicase in c-H-ras alternative splicing regulation.

Authors:  Sònia Guil; Renata Gattoni; Montserrat Carrascal; Joaquín Abián; James Stévenin; Montse Bach-Elias
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

Review 7.  Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression.

Authors:  Zhi-Ming Zheng
Journal:  J Biomed Sci       Date:  2004 May-Jun       Impact factor: 8.410

8.  A complex intronic splicing enhancer from the c-src pre-mRNA activates inclusion of a heterologous exon.

Authors:  E F Modafferi; D L Black
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

9.  A pyrimidine-rich exonic splicing suppressor binds multiple RNA splicing factors and inhibits spliceosome assembly.

Authors:  Z M Zheng; M Huynen; C C Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

10.  Selection and characterization of replication-competent revertants of a Rous sarcoma virus src gene oversplicing mutant.

Authors:  L Zhang; S B Simpson; C M Stoltzfus
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.